510(k) K253490
K253490 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions". The FDA issued a decision of Substantially Equivalent on February 12, 2026. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Roche Diagnostics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 12, 2026
- Date Received
- October 24, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type